300+ investors in your industry, stage, and region Get
Any industry
Video Games
Hospitality
EdTech
Restaurants
Google
Construction
Photography
Cryptocurrency
Clean Energy
CleanTech
Big Data
Email
Artificial Intelligence
Social Impact
Mobile
SaaS
Energy
Consumer
Enterprise Software
Health Care
Platforms
Travel
Local
InsurTech
Oil and Gas
Retail
Payments
Film
Marketplace
Organic Food
Fitness
Machine Learning
Agriculture (AgTech)
Gaming
Facebook
B2B
Blockchain
Social Network
Medical Device
Sports
Education
Wellness
Automotive
Biotechnology
eSports
Legal
Software
Renewable Energy
Crowdfunding
Recruiting
Venture Capital
Web3
Medical
Theatre
Climate
Social
LGBT
Cannabis
Infrastructure
Celebrity
Life Science
Food and Beverage
Beauty
Publishing
Mobile Apps
Wine and Spirits
Fashion
Music
Art
Real Estate
Sporting Goods
Manufacturing
Social Media
Financial Services
Franchise
FinTech
Non Profit
Internet
Finance
Mobile Advertising
Android
Proptech
Impact
Sustainability
Hardware
Digital Media
Biotech
Transportation
Enterprise
Community
Media (Entertainment)
Any country
Afghanistan
Greece
United Kingdom
Thailand
United Arab Emirates
Andorra
Benin
South Korea
Japan
Burkina Faso
Africa
Singapore
Brazil
LATAM
Gibraltar
Egypt
Taiwan
Zimbabwe
Tunisia
Sweden
Oceania
Nigeria
Hong Kong
Togo
Croatia
Iran
Guinea
Haiti
Lesotho
Kyrgyzstan
Norway
Isle of Man
Liberia
Malawi
Nepal
Mexico
Madagascar
Russian Federation
Sudan
Pakistan
Tajikistan
Zambia
Romania
Oman
Poland
Puerto Rico
Cameroon
Guernsey
Colombia
China
Armenia
Czech Republic
Costa Rica
Kenya
Kuwait
Marshall Islands
Malta
Luxembourg
Mozambique
Namibia
Mauritius
Nicaragua
Serbia
Panama
Uzbekistan
Australia
New Zealand
Morocco
Saudi Arabia
Sri Lanka
Jamaica
Guatemala
Switzerland
Kazakhstan
Cayman Islands
Myanmar
Venezuela
Turkey
Uruguay
Uganda
Moldova
Seychelles
Botswana
Paraguay
South Africa
Canada
Ireland
France
Denmark
Georgia
Ghana
Iraq
Latvia
Malaysia
Philippines
Portugal
Rwanda
Sierra Leone
El Salvador
Senegal
Tanzania
Mali
India
Germany
United States
Indonesia
Dominican Republic
Middle East
Bermuda
Asia
Albania
Argentina
Spain
Europe
Qatar
Angola
Cyprus
Barbados
Belgium
Jordan
Ethiopia
Bangladesh
Austria
Azerbaijan
Bulgaria
Ecuador
Faroe Islands
Jersey
Bahrain
Estonia
Bahamas
Bolivia
Belize
Algeria
Italy
Belarus
Finland
Hungary
Grenada
Israel
Lithuania
Honduras
Iceland
Cambodia
Liechtenstein
Lebanon
Mongolia
Peru
Slovenia
San Marino
Ukraine
Chile
Vietnam
Angel Investors
VC Funds
All Investors
Access Full Database - Free Forever
Open database
Sunshine Insurance Group, VC Fund

Sunshine Insurance Group

VC Fund

Beijing, China

Sunshine Insurance Group is a VC fund in Beijing focused on Health Care and Biotechnology. Sunshine Insurance Group Company Limited provides insurance products and services.

Total investments:
27
Last investment:
Lead investor:
30%

Last updated:

Industries Sunshine Insurance Group invests in

Health CareBiotechnologyMedicalInternetArtificial Intelligence

Stages Sunshine Insurance Group invests in

Series CSeries BSeries DSeries EAngel

Countries Sunshine Insurance Group invests in

ChinaUnited States

Round sizes

Series B $11M–$186MSeries C $4.6M–$460MSeries D $7.2M–$200M

Contacts

NameEmailPhoneSocials

Sign up to unlock verified contacts

Unlock Contacts

Round size

Series B
$11M–$186M
Series C
$4.6M–$460M
Series D
$7.2M–$200M

Investment Focus

Industry

  • Health Care 5 (19%)
  • Biotechnology 5 (19%)
  • Medical 4 (15%)
  • Internet 3 (11%)
  • Artificial Intelligence 3 (11%)
See all 51 industries →

Stage

  • Series C 12 (44%)
  • Series B 7 (26%)
  • Series D 3 (11%)
  • Series E 2 (7%)
  • Angel 1 (4%)
See all 7 stages →

Country

  • China 24 (89%)
  • United States 1 (4%)

Team

NameTitleInvestmentsLinksEmail
Phil Tian
Phil Tian Chief Data Scientist, Big Data Centre
Chief Data Scientist, Big Data Centre Total investments: 0
Find email
Zhang Weigong
Zhang Weigong Founder
Founder Total investments: 0 Find email

Investments

CompanyDescriptionRoundLinks
Hugemed manufactures of medical devices and provides solutions in the field of endoscopy. Series C / Mar 30, 2026
Zhejiang Boner Medical Investment Management Co., Ltd. is a well-known professional hospital investment operator in the Yangtze River Delta, featuring major orthopaedics and rehabilitation. $109.8M / Series E / Nov 09, 2023
Data Grand is a semantic analysis solution developer. $91.8M / Series C / Mar 09, 2022
Grit Science
Grit Science is a gene therapeutics firm, that engages in the R&D of liver genes. $15M / Series A / Mar 02, 2022
ChangXin Memory Technologies specializes in manufacturing dynamic random-access memory (DRAM) semiconductor products. $1.2B / Series C / Feb 17, 2022
Zaihui is a SaaS-based data-driven marketing automation solution for local businesses that offers them with member management, precipitation members, incentive members, and mining member values. Product system offers intelligent precision marketing, integral marketing, stored-value marketing, anniversary marketing, attendant performance, thememarketing activities, and brand packaging marketing.Zaihui is headquartered in China and the company was founded in 2015. $200M / Series D / Jan 11, 2022
ImmuneOnco Biopharma, founded in June of 2015 in Zhangjiang High-Tech Park of Shanghai, China, is an early stage biopharmaceutical company dedicated to the development and commercialization of novel cancer immunotherapy products designed to reverse cancer cell-induced immune inhibition and to actively eradicate cancer cells. $100M / Series C / Jan 01, 2022
XuanZhu Pharma is an innovative biopharmaceutical company rooted in China, with a global perspective, focusing on tumors, metabolic diseases, infections, and other fields. It has a layout of the entire industry chain from drug discovery, preclinical research, clinical development, and production and sales. $96.1M / Series B / Dec 31, 2021
ImmuneOnco Biopharma, founded in June of 2015 in Zhangjiang High-Tech Park of Shanghai, China, is an early stage biopharmaceutical company dedicated to the development and commercialization of novel cancer immunotherapy products designed to reverse cancer cell-induced immune inhibition and to actively eradicate cancer cells. $100M / Venture - Series Unknown / Dec 31, 2021
Neurophth is China's first gene therapy company for ophthalmic diseases. As a clinical-stage company, Neurophth is dedicated to discovering and developing gene therapies for patients suffering from blindness and other eye diseases globally. $60M / Series C / Nov 23, 2021
See all 27 investments →

Co-Investors

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!

Find investors for your startup

Search 48,091 investors by industry and country. Emails and phones included.

Any industry
Video Games
Hospitality
EdTech
Restaurants
Google
Construction
Photography
Cryptocurrency
Clean Energy
CleanTech
Big Data
Email
Artificial Intelligence
Social Impact
Mobile
SaaS
Energy
Consumer
Enterprise Software
Health Care
Platforms
Travel
Local
InsurTech
Oil and Gas
Retail
Payments
Film
Marketplace
Organic Food
Fitness
Machine Learning
Agriculture (AgTech)
Gaming
Facebook
B2B
Blockchain
Social Network
Medical Device
Sports
Education
Wellness
Automotive
Biotechnology
eSports
Legal
Software
Renewable Energy
Crowdfunding
Recruiting
Venture Capital
Web3
Medical
Theatre
Climate
Social
LGBT
Cannabis
Infrastructure
Celebrity
Life Science
Food and Beverage
Beauty
Publishing
Mobile Apps
Wine and Spirits
Fashion
Music
Art
Real Estate
Sporting Goods
Manufacturing
Social Media
Financial Services
Franchise
FinTech
Non Profit
Internet
Finance
Mobile Advertising
Android
Proptech
Impact
Sustainability
Hardware
Digital Media
Biotech
Transportation
Enterprise
Community
Media (Entertainment)
Any country
Afghanistan
Greece
United Kingdom
Thailand
United Arab Emirates
Andorra
Benin
South Korea
Japan
Burkina Faso
Africa
Singapore
Brazil
LATAM
Gibraltar
Egypt
Taiwan
Zimbabwe
Tunisia
Sweden
Oceania
Nigeria
Hong Kong
Togo
Croatia
Iran
Guinea
Haiti
Lesotho
Kyrgyzstan
Norway
Isle of Man
Liberia
Malawi
Nepal
Mexico
Madagascar
Russian Federation
Sudan
Pakistan
Tajikistan
Zambia
Romania
Oman
Poland
Puerto Rico
Cameroon
Guernsey
Colombia
China
Armenia
Czech Republic
Costa Rica
Kenya
Kuwait
Marshall Islands
Malta
Luxembourg
Mozambique
Namibia
Mauritius
Nicaragua
Serbia
Panama
Uzbekistan
Australia
New Zealand
Morocco
Saudi Arabia
Sri Lanka
Jamaica
Guatemala
Switzerland
Kazakhstan
Cayman Islands
Myanmar
Venezuela
Turkey
Uruguay
Uganda
Moldova
Seychelles
Botswana
Paraguay
South Africa
Canada
Ireland
France
Denmark
Georgia
Ghana
Iraq
Latvia
Malaysia
Philippines
Portugal
Rwanda
Sierra Leone
El Salvador
Senegal
Tanzania
Mali
India
Germany
United States
Indonesia
Dominican Republic
Middle East
Bermuda
Asia
Albania
Argentina
Spain
Europe
Qatar
Angola
Cyprus
Barbados
Belgium
Jordan
Ethiopia
Bangladesh
Austria
Azerbaijan
Bulgaria
Ecuador
Faroe Islands
Jersey
Bahrain
Estonia
Bahamas
Bolivia
Belize
Algeria
Italy
Belarus
Finland
Hungary
Grenada
Israel
Lithuania
Honduras
Iceland
Cambodia
Liechtenstein
Lebanon
Mongolia
Peru
Slovenia
San Marino
Ukraine
Chile
Vietnam
Angel Investors
VC Funds
All Investors

Similar Investors

Recommended lists

FAQ

What does Sunshine Insurance Group invest in?

Sunshine Insurance Group invests primarily in Health Care, Biotechnology and Medical startups, most often at Series C and Series B stage. Most of the 27 investments tracked by Shizune back companies in China. The Investment Focus section breaks down every industry, stage and country in the portfolio.

What round sizes does Sunshine Insurance Group invest in?

Sunshine Insurance Group typically joins rounds of $11M–$186M at Series B, $4.6M–$460M at Series C and $7.2M–$200M at Series D. These are whole funding-round sizes, not Sunshine Insurance Group's own check, which is rarely disclosed: the 10th–90th percentile of the confirmed public funding rounds Sunshine Insurance Group took part in.

How do I contact Sunshine Insurance Group?

Public channels for Sunshine Insurance Group include LinkedIn, X (Twitter) and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

Who are the partners at Sunshine Insurance Group?

The team at Sunshine Insurance Group includes Phil Tian (Chief Data Scientist, Big Data Centre) and Zhang Weigong (Founder). The Team section lists each member with their title, investment count and links.

Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Oct 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

Contact your first 100 investors today

Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.

Find investors — It's Free!
Sunshine Insurance Group Sunshine Insurance Group Find emails